Prolonged treatment with prostaglandin in an infant born with extremely low weight

Area of Science:

• Pediatric Cardiology
• Neonatology
• Congenital Heart Disease

Background:

• Duct-dependent cardiac disease requires maintaining ductal patency for systemic blood flow.
• Premature infants with low birth weight present unique challenges in managing critical congenital heart disease.

Purpose of the Study:

• To report the successful management of a premature infant with duct-dependent congenital heart disease.
• To highlight the role of prostaglandin infusion in stabilizing extremely low birth weight infants with critical cardiac conditions.

Main Methods:

• Prenatal diagnosis of duct-dependent cardiac disease.
• Management of a premature, extremely low birth weight infant.
• Prostaglandin E1 infusion to maintain ductus arteriosus patency.
• Neonatal intensive care and weight monitoring.

Main Results:

• Prostaglandin infusion successfully maintained ductal patency for 66 days.
• The infant achieved significant weight gain under neonatal intensive care.
• Facilitated transfer for palliative cardiac surgery.

Conclusions:

• Prostaglandin therapy is crucial for stabilizing infants with duct-dependent congenital heart disease.
• Extended ductal patency can enable necessary weight gain in extremely premature infants before surgical intervention.
• This case demonstrates a successful strategy for managing complex neonatal cardiac conditions.